AU5060499A - Hydrodynamically balanced oral drug delivery system - Google Patents

Hydrodynamically balanced oral drug delivery system

Info

Publication number
AU5060499A
AU5060499A AU50604/99A AU5060499A AU5060499A AU 5060499 A AU5060499 A AU 5060499A AU 50604/99 A AU50604/99 A AU 50604/99A AU 5060499 A AU5060499 A AU 5060499A AU 5060499 A AU5060499 A AU 5060499A
Authority
AU
Australia
Prior art keywords
delivery system
drug delivery
oral drug
hydrodynamically balanced
balanced oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU50604/99A
Other languages
English (en)
Inventor
John N. Staniforth
Naresh Talwar
Michael J. Tobyn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ranbaxy Laboratories Ltd
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Publication of AU5060499A publication Critical patent/AU5060499A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU50604/99A 1999-08-04 1999-08-04 Hydrodynamically balanced oral drug delivery system Abandoned AU5060499A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB1999/001386 WO2001010405A1 (en) 1999-08-04 1999-08-04 Hydrodynamically balanced oral drug delivery system

Publications (1)

Publication Number Publication Date
AU5060499A true AU5060499A (en) 2001-03-05

Family

ID=11004886

Family Applications (2)

Application Number Title Priority Date Filing Date
AU50604/99A Abandoned AU5060499A (en) 1999-08-04 1999-08-04 Hydrodynamically balanced oral drug delivery system
AU63099/00A Ceased AU774957B2 (en) 1999-08-04 2000-08-01 Hydrodynamically balancing oral drug delivery system

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU63099/00A Ceased AU774957B2 (en) 1999-08-04 2000-08-01 Hydrodynamically balancing oral drug delivery system

Country Status (21)

Country Link
EP (1) EP1206249A4 (xx)
JP (1) JP2003506400A (xx)
CN (1) CN1376059A (xx)
AP (1) AP2002002410A0 (xx)
AU (2) AU5060499A (xx)
BR (1) BR0012981A (xx)
CA (1) CA2378468A1 (xx)
CZ (1) CZ2002415A3 (xx)
EA (1) EA200200126A1 (xx)
HK (1) HK1047226A1 (xx)
HR (1) HRP20020108A2 (xx)
HU (1) HUP0202497A3 (xx)
IL (1) IL147966A0 (xx)
MX (1) MXPA02001272A (xx)
NZ (1) NZ516959A (xx)
OA (1) OA12003A (xx)
PL (1) PL353321A1 (xx)
SK (1) SK1832002A3 (xx)
TR (1) TR200200467T2 (xx)
WO (2) WO2001010405A1 (xx)
ZA (1) ZA200200926B (xx)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100457458B1 (ko) * 2001-04-02 2004-11-17 삼아약품 주식회사 속용정 및 그의 제조방법
AU2002355686B2 (en) 2001-07-04 2007-11-29 Sun Pharmaceutical Industries Limited Gastric retention controlled drug delivery system
WO2003037296A2 (en) * 2001-10-29 2003-05-08 Labopharm Inc. Methods and dosage forms for improving the bioavailability of therapeutic agents
US20050226926A1 (en) 2002-07-25 2005-10-13 Pfizer Inc Sustained-release tablet composition of pramipexole
WO2005020879A2 (en) * 2003-08-27 2005-03-10 Vecta Ltd. Compositions for treating pathologies that necessitate suppression of gastric acid secretion
TW200533391A (en) * 2004-03-25 2005-10-16 Sun Pharmaceutical Ind Ltd Gastric retention drug delivery system
BRPI0513846A (pt) 2004-08-13 2008-05-20 Boehringer Ingelheim Int formulação de comprimido de liberação prolongada contendo pramipexol ou um sal farmaceuticamente aceitável do mesmo, método para a fabricação do mesmo e o uso do mesmo
DE102004042139B4 (de) * 2004-08-31 2009-06-10 Aristocon Verwaltungs- Gmbh Perorale Darreichungsformen zur Erzielung eines Retardierungseffektes nach der Arzneimitteleinnahme mit einer Mahlzeit
EP1690540A1 (en) * 2005-02-15 2006-08-16 Neuro3D Composition comprising ocaperidone
US9301919B2 (en) 2005-12-22 2016-04-05 Oakwood Laboratories, Llc Sublimable sustained release delivery system and method of making same
EP1886665A1 (en) * 2006-08-01 2008-02-13 Boehringer Ingelheim Pharma GmbH & Co. KG Gastro retentive delivery system
ATE476176T1 (de) 2007-03-02 2010-08-15 Farnam Co Inc Wachsähnliches material enthaltende tabletten mit verzögerter freisetzung
CN102202656A (zh) 2008-08-15 2011-09-28 蒂宝制药公司 治疗和预防cns障碍的胃滞留药用组合物
JP2012500230A (ja) 2008-08-18 2012-01-05 北京天衡▲薬▼物研究院 胃内滞留薬物放出システム及びその製造方法と使用
AU2009301994B2 (en) 2008-10-08 2016-10-20 Bioplus Life Sciences Pvt. Ltd. Sustained release drug delivery system
EP2283824B1 (en) 2009-07-30 2017-04-19 Special Products Line S.p.A. Compositions and formulations based on swellable matrices for sustained release of poorly soluble drugs such as clarithromycin
JP2013103879A (ja) * 2011-11-10 2013-05-30 Nakanihon Capsule Co Ltd ハードカプセル
KR102241487B1 (ko) 2013-02-20 2021-04-16 주식회사 종근당 제어방출 펠릿으로 된 약제학적 조성물
ES2761407T3 (es) * 2013-03-15 2020-05-19 Aprecia Pharmaceuticals LLC Forma de dosificación rápidamente dispersable de topiramato
CN103462917A (zh) * 2013-09-12 2013-12-25 南京正宽医药科技有限公司 一种用于抗病毒的阿昔洛韦片剂及其制备方法
CN109561710A (zh) * 2016-06-14 2019-04-02 普瑞特克微生物有限责任公司 包含饲料添加剂的动物饲料颗粒、其制备和使用方法
US10588863B2 (en) 2017-06-16 2020-03-17 Kashiv Biosciences, Llc Extended release compositions comprising pyridostigmine
US10987311B2 (en) 2017-06-16 2021-04-27 Kashiv Specialty Pharmaceuticals, Llc Extended release compositions comprising pyridostigmine
US10918597B2 (en) 2017-06-16 2021-02-16 Kashiv Specialty Pharmaceuticals, Llc Gastroretentive dosage forms for sustained drug delivery
CN107375287B (zh) * 2017-08-22 2019-11-29 安徽省肿瘤医院 一种硫酸阿托品在制备治疗原发性肝癌药物中的用途
CN107349195A (zh) * 2017-08-22 2017-11-17 安徽省肿瘤医院 一种维拉帕米在制备治疗转移性肝癌药物中的用途
CN107441115A (zh) * 2017-08-22 2017-12-08 安徽省肿瘤医院 一种维拉帕米联合碳酸氢钠在制备原发性肝癌治疗药物中的用途
EP4056172A1 (en) 2018-06-18 2022-09-14 Amneal Complex Products Research LLC Extended release compositions comprising pyridostigmine
JP7034343B2 (ja) 2018-06-27 2022-03-11 アムニール コンプレックス プロダクツ リサーチ エルエルシー 自己調節性の浸透性胃保持性薬物送達システム
US11389398B2 (en) 2019-05-14 2022-07-19 Clexio Biosciences Ltd. Gastroretentive treatment of nocturnal symptoms and morning akinesia in subjects with parkinson's disease
WO2022195476A1 (en) 2021-03-15 2022-09-22 Clexio Biosciences Ltd. Gastroretentive devices for assessment of intragastric conditions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH675537A5 (xx) * 1988-03-25 1990-10-15 Ciba Geigy Ag
US5096714A (en) * 1988-06-28 1992-03-17 Hauser-Kuhrts, Inc. Prolonged release drug tablet formulations
US5368861A (en) * 1989-10-26 1994-11-29 Nippon Shinyaku Co., Ltd. Gastric preparation with sustained release
MX9300110A (es) * 1992-01-13 1994-07-29 Gerhard Gergely Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.
GB9322314D0 (en) * 1993-10-29 1993-12-15 Scherer Ltd R P Foam generating capsules
DE4403943A1 (de) * 1994-02-08 1995-08-10 Hexal Pharma Gmbh Orale Azrneimittelzubereitung mit Diclofenac-Natrium
GB9418530D0 (en) * 1994-09-14 1994-11-02 Glaxo Group Ltd Medicaments
US5788987A (en) * 1997-01-29 1998-08-04 Poli Industria Chimica Spa Methods for treating early morning pathologies
IT1293764B1 (it) * 1997-07-23 1999-03-10 Chiesi Farma Spa Composizioni farmaceutiche sotto forma di compresse effervescenti contenenti un principio attivo instabile in presenza di acqua

Also Published As

Publication number Publication date
JP2003506400A (ja) 2003-02-18
EP1206249A1 (en) 2002-05-22
AU774957B2 (en) 2004-07-15
AU6309900A (en) 2001-03-05
NZ516959A (en) 2003-10-31
CN1376059A (zh) 2002-10-23
EA200200126A1 (ru) 2002-10-31
PL353321A1 (en) 2003-11-17
IL147966A0 (en) 2002-09-12
HUP0202497A3 (en) 2004-05-28
EP1206249A4 (en) 2004-12-22
ZA200200926B (en) 2002-11-27
OA12003A (en) 2006-04-18
BR0012981A (pt) 2002-06-18
WO2001010419A1 (en) 2001-02-15
HUP0202497A2 (hu) 2002-11-28
SK1832002A3 (en) 2002-08-06
HRP20020108A2 (en) 2003-12-31
CZ2002415A3 (cs) 2002-08-14
MXPA02001272A (es) 2002-07-22
WO2001010405A1 (en) 2001-02-15
TR200200467T2 (tr) 2002-08-21
AP2002002410A0 (en) 2002-03-31
CA2378468A1 (en) 2001-02-15
HK1047226A1 (zh) 2003-02-14

Similar Documents

Publication Publication Date Title
AU5060499A (en) Hydrodynamically balanced oral drug delivery system
AU3287699A (en) Ultrasound-mediated drug delivery
GB9904629D0 (en) Oral drug delivery system
AU2123200A (en) Drug delivery device
AU4981200A (en) Stent delivery system
AU4985600A (en) Drug delivery device
AU6938600A (en) Cervical agent delivery system
AU5259100A (en) Medicament
AU4357800A (en) Intracellular pharmaceutical targeting
AU4661700A (en) Content delivery system
AU4947100A (en) Drug delivery device
AU3520900A (en) Implantable drug delivery system
AU2002343555A1 (en) Eutectic-based self-nanoemulsified drug delivery system
EP1061987A4 (en) DEVICE FOR ADMINISTERING A MEDICINAL PRODUCT
AU7711098A (en) Drug delivery system
AU7201998A (en) Drug delivery system
AU6715600A (en) Pharmaceutical formulations
AU3837999A (en) Drug delivery device
AU4977300A (en) Pharmaceutical formulations
AU1385801A (en) Pharmaceutical formulations
AU6503399A (en) Drug delivery catheter
AU3926000A (en) Methods and compositions for drug delivery
AU2002222138A1 (en) Drug delivery system
AU2002210580A1 (en) Drug delivery system
AU1413700A (en) Information delivery system

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase